No link between mobile phones, brain cancer, finds WHO-backed study

The final analysis included 63 studies from 1994-2022, assessed by 11 investigators from 10 countries, including the Australian government's radiation protection authority

Union Budget, Budget 2024, mobile phones, smartophone, telecom
The agency's advisory group has called for the classification to be re-evaluated as soon as possible given the new data since its last assessment in 2011.
Reuters LONDON
2 min read Last Updated : Sep 03 2024 | 10:04 PM IST
There is no link between mobile phone use and an increased risk of brain cancer, according to a new World Health Organization-commissioned review of available published evidence worldwide.
 
Despite the huge rise in the use of wireless technology, there has not been a corresponding increase in the incidence of brain cancers, the review, published on Tuesday, found. That applies even to people who make long phone calls or those who have used mobile phones for more than a decade.
 
The final analysis included 63 studies from 1994-2022, assessed by 11 investigators from 10 countries, including the Australian government's radiation protection authority.
 
The work assessed the effects of radiofrequency, used in mobile phones as well as TV, baby monitors and radar, co-author Mark Elwood, professor of cancer epidemiology at the University of Auckland, New Zealand, said.
 
"None of the major questions studied showed increased risks," he said. The review looked at cancers of the brain in adults and children, as well as cancer of the pituitary gland, salivary glands and leukemia, and risks linked to mobile phone use, base stations, or transmitters, as well as occupational exposure. Other cancer types will be reported separately.
 
The review follows other similar work. The WHO and other international health bodies have said previously there is no definitive evidence of adverse health effects from the radiation used by mobile phones, but called for more research. It is currently classified as "possibly carcinogenic", or class 2B, by the International Agency for Research on Cancer (IARC), a category used when the agency cannot rule out a potential link.
 
The agency's advisory group has called for the classification to be re-evaluated as soon as possible given the new data since its last assessment in 2011.
 
WHO's evaluation will be released in the first quarter of next year.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :WHOMobile phones

First Published: Sep 03 2024 | 10:04 PM IST

Next Story